Viking Therapeutics Inc
LSE:0VQA
Viking Therapeutics Inc
LSE:0VQA
Price:
40.16
USD
1.41%
Market Closed
Market Cap:
$4.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Viking Therapeutics Inc
LSE:0VQA
|
US |
|
A
|
Arista Networks Inc
F:117
|
US |
|
Scor SE
F:SDRB
|
FR |
|
Caixabank SA
F:48CA
|
ES |
|
C
|
China Pacific Insurance Group Co Ltd
LSE:CPIC
|
CN |
|
I
|
InterDigital Inc
SWB:IDI
|
US |
|
S
|
Star7 SpA
F:EH2
|
IT |
|
B
|
Bilfinger SE
XHAM:GBF
|
DE |
Wall St Price Targets
0VQA Price Targets Summary
Viking Therapeutics Inc
Viking Therapeutics Inc
Wall Street analysts forecast 0VQA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 0VQA is 91.48 USD with a low forecast of 33.04 USD and a high forecast of 126.27 USD.
Lowest Forecast
Price Target
33.04
USD
18% Downside
Average Forecast
Price Target
91.48
USD
128% Upside
Highest Forecast
Price Target
126.27
USD
214% Upside
Viking Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0VQA's stock price target?
Price Target
91.48
USD
91.48
USD
According to Wall Street analysts, the average 1-year price target for 0VQA is 91.48 USD with a low forecast of 33.04 USD and a high forecast of 126.27 USD.
